Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Vertex’s triple combination cystic fibrosis therapy Alyftrek approved by MHRA

Over 11,000 people in the UK are affected by the rare genetic disease

- PMLiVE

J&J/Protagonist’s icotrokinra shows promise in phase 3 plaque psoriasis programme

More than 125 million people worldwide are estimated to be living with the immune-mediated skin disease

- PMLiVE

Michelle Worst Honored With 2025 HOPA Volunteer Award

Medscape is proud to highlight Michelle A. Worst, PharmD, BCOP, MBA, CHCP, Senior Director and Team Lead of Clinical Strategy in Hematology/Oncology, for her well-deserved recognition as the recipient of...

Medscape Education

- PMLiVE

BMS granted EC approval for immunotherapy combination in liver cancer

More than 866,100 cases of the disease were diagnosed globally in 2022

- PMLiVE

Organon shares positive long-term results for Vtama cream in atopic dermatitis

The common inflammatory skin disease affects more than 26 million people in the US alone

- PMLiVE

FDA approves Celltrion’s denosumab biosimilars Stoboclo and Osenvelt

The drugs have been authorised for all indications covered by Amgen’s bone disease therapy

- PMLiVE

Preparing biotechs for spin-out and beyond

Part 2: The spin-out process – a practical guide

- PMLiVE

Innovations in Women’s Health Coalition Launches New Global Efforts

Medscape Education, the leader in continuing medical education for healthcare professionals, is extending its commitment to closing gaps in women's health by expanding the efforts of its Innovations in Women's...

Medscape Education

- PMLiVE

J&J’s Lazcluze/Rybrevant combination granted MHRA approval for lung cancer

Approximately 47,000 people are diagnosed with lung cancer every year in the UK

- PMLiVE

AstraZeneca announces promising late-stage results for Imfinzi in gastric cancer

Almost one million cases of the disease are diagnosed globally every year

- PMLiVE

Takeda/Protagonist share positive phase 3 results for rusfertide in rare blood cancer

Up to 160,000 people in the US are affected by polycythaemia vera

- PMLiVE

What is it all for?

The role of healthcare comms in the fight to help improve health and wellness

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links